First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.

Citation: Mladenova G, Annedi SC, Ramnauth J, Maddaford SP, Rakhit S, Andrews JS, Zhang D, Porreca F.: First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain. J Med Chem, Volume 55 (7), 2012
Authors: Andrews JS, Annedi SC, Maddaford SP, Mladenova G, Porreca F., Rakhit S, Ramnauth J, Zhang D
Journal: J Med Chem
Year: 2012
DOI: 10.1021/jm300138g
PubMed: 22420844
Machine-readable: REST API RDF

Publication